Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,758,867 | $2,499,766 | $2,084,279 | $1,767,087 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Cost of Goods Sold | $840,200 | $737,600 | $661,361 | $458,757 |
| Gross Profit | $1,918,667 | $1,762,166 | $1,422,918 | $1,308,330 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| R&D Expenses | $431,210 | $426,927 | $394,191 | $385,646 |
| G&A Expenses | $1,420,600 | $1,394,600 | $663,381 | $801,262 |
| SG&A Expenses | $1,668,100 | $1,620,300 | $1,593,025 | $1,663,151 |
| Sales & Mktg Exp. | $247,500 | $225,700 | $929,644 | $861,889 |
| Other Operating Expenses | $868,060 | -$70,049 | $29,213 | $115,211 |
| Operating Expenses | $2,967,370 | $1,977,178 | $2,016,429 | $2,164,008 |
| Operating Income | -$1,048,703 | -$215,012 | -$593,511 | -$855,678 |
| % Margin | -38% | -8.6% | -28.5% | -48.4% |
| Other Income/Exp. Net | $12,542 | $13,266 | -$39,059 | $13,172 |
| Pre-Tax Income | -$1,036,161 | -$201,746 | -$632,570 | -$842,506 |
| Tax Expense | -$7,304 | $2,403 | -$9,064 | -$246,881 |
| Net Income | -$1,028,857 | -$204,149 | -$623,506 | -$595,625 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| Weighted Avg Shares Out | 184,197 | 180,144 | 176,351 | 171,348 |
| Weighted Avg Shares Out Dil | 184,197 | 180,144 | 176,351 | 171,348 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $31,974 | $24,421 | $13,907 | $12,879 |
| Depreciation & Amortization | $214,859 | $206,608 | $197,558 | $180,346 |
| EBITDA | -$789,328 | $29,283 | -$421,105 | -$649,281 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |